Riskpilot← Back to searchSign inGet full accessHRN Medical AB
ABActiveOrg 5590987516Linnégatan 65Other education n.e.c. · NACE 8559Est. 20171-4 employees
Revenue 2024
SEK 558K
+386% vs 2023
EBITDA margin
52.7%
+343% vs 2023
Equity ratio
65.6%
Financial strength
Net profit 2024
SEK 1,6M
+726% vs 2023
| Revenue | SEK 558K | +386% |
| EBITDA | SEK 294K | +343% |
| Net profit | SEK 1,6M | +726% |
| Total assets | SEK 2,5M | +1719% |
| Equity | SEK 1,7M | +2324% |
| Employees | — | — |
Legal name
HRN Medical AB
Org number
5590987516
Legal form
Aktiebolag
NACE code
8559 · Other education n.e.c.
Founded
30 januari 2017
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva medicinsk och estetisk konsultverksamhet inom specialistläkartjänster. Bolaget skall även handla med värdepapper, investera i aktier samt därmed förenlig verksamhet.
Address
Linnégatan 65
Email
hamidreza.natghian@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 26 | 115 | 558 |
| Staff expenses | — | — | −221 | −2 | −8 |
| EBITDA | −157 | −132 | −451 | −121 | 294 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −157 | −132 | −451 | −121 | 294 |
| Net financials | — | 200 | 388 | 364 | 2 050 |
| Profit before tax | −158 | 67 | −64 | 243 | 2 054 |
| Tax | −0 | −1 | −12 | −49 | −450 |
| Net profit | −158 | 66 | −75 | 194 | 1 604 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 26 | 187 | 403 | 139 | 2 522 |
| Equity | 26 | 92 | 50 | 68 | 1 655 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 0 | 95 | 353 | 70 | 578 |
| Total debt | — | 95 | 353 | 70 | 578 |
EBITDA margin
52.7%
This company
15.8%
Market median
+234% vs market
20202024
Equity ratio
65.6%
This company
38.2%
Market median
+72% vs market
20202024
Return on equity
97.0%
This company
18.4%
Market median
+427% vs market
20202024
Net profit margin
287.6%
This company
8.1%
Market median
+3451% vs market
20202024
Asset turnover
0.22×
This company
1.12×
Market median
-80% vs market
20202024
Debt / equity
0.52×
This company
0.62×
Market median
+16% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2023 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HRN Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Amirhosein Natghian | Deputy Board Member | 0 companies |
| Hamidreza Natghian | Board of Directors | 0 companies |
| Massoud Natghian | Deputy Board Member | 0 companies |